首页|儿童清咽解热口服液联合克拉霉素治疗急性上呼吸道感染的临床观察

儿童清咽解热口服液联合克拉霉素治疗急性上呼吸道感染的临床观察

扫码查看
目的:评估儿童清咽解热口服液联合克拉霉素治疗上呼吸道感染的临床效果.方法:选取 2022 年 12 月—2023 年 6 月广州中医药大学金沙洲医院收治的 120 例急性上呼吸道感染患儿作为研究对象,随机分为观察组和对照组,每组各 60 例.对照组以予克拉霉素分散片治疗,观察组在对照组治疗的基础上予以儿童清咽解热口服液治疗.治疗 5 d后观察两组临床症状积分的变化、完全退热时间、血象复常时间、血象/炎症因子变化、布洛芬使用情况及安全性情况.结果:两组治疗 5 d后症状积分均降低,且观察组降低更明显,差异有统计学意义(P<0.05);观察组完全退热时间、血常规复常时间均明显短于对照组,差异有统计学意义(P<0.05);两组治疗5 d后的白细胞(WBC)、中性粒细胞(NEUT)、白细胞介素6(IL-6)和肿瘤坏死因子-α(TNF-α)均降低,且观察组降低更明显,差异有统计学意义(P<0.05);观察组退热药布洛芬的使用显著少于对照组,差异有统计学意义(P<0.05).观察和治疗期间,两组未发现与药物使用相关的不良事件,安全性良好.结论:儿童清咽解热口服液与克拉霉素联合使用治疗急性上呼吸道感染,能明显改善症状,缩短病程,改善血象异常和炎症因子的表达.
Clinical Observation of Ertong Qingyan Jiere Koufuye Combined with Clarithromycin in Treatment of Acute Upper Respiratory Tract Infection
Objective:To evaluate the clinical effect of Ertong Qingyan Jiere Koufuye combined with clarithromycin in the treatment of upper respiratory tract infection.Method:A total of 120 children with acute upper respiratory tract infection admitted to Jinshazhou Hospital of Guangzhou University of Traditional Chinese Medicine from December 2022 to June 2023 were selected as the study subjects and were randomly divided into observation group and control group,with 60 cases in each group.The control group was treated with clarithromycin dispersive tablets,and the observation group was treated with Ertong Qingyan Jiere Koufuye on the basis of the control group.After 5 days of treatment,the changes of clinical symptom score,complete fever regression time,blood image recovery time,blood image/inflammatory factor changes,ibuprofen use and safety in the two groups were observed.Result:After 5 days of treatment,the symptom scores of both groups were decreased,and the decrease was more obvious in the observation group,with statistical significance(P<0.05).The time of complete fever regression and the time of routine blood routine normalization in the observation group were significantly shorter than those in the control group,and the differences were statistically significant(P<0.05).After 5 days of treatment,white blood cell count(WBC),neutrophil(NEUT),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)were decreased in both groups,and the decrease was more significant in the observation group,the difference was statistically significant(P<0.05).The use of ibuprofen was significantly lower in the observation group than that in the control group.During observation and treatment,no adverse events related to drug use were found in the two groups,and the safety was good.Conclusion:The combination of clarithromycin and Ertong Qingyan Jiere Koufuye in the treatment of acute upper respiratory tract infection can significantly improve symptoms,shorten the course of the disease,improve the abnormal blood image and inflammatory factor expression.

Acute upper respiratory tract infectionErtong Qingyan Jiere KoufuyeClarithromycinControl observationInflammatory factors

黄翠珍

展开 >

广州中医药大学金沙洲医院 广东 广州 510168

急性上呼吸道感染 儿童清咽解热口服液 克拉霉素 对照观察 炎症因子

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(27)